In a large nationwide population of 788 persons with hemophilia A of all severities, we investigated the prevalence and characteristics of FVIII-specific NNA, very low-titer inhibitors (assessed with the recently developed NusBA), and inhibitors (assessed with the NBA). The gene discussed is F8; the disease is hemophilia A.